109 related articles for article (PubMed ID: 25628311)
1. Retinal ganglion cell neuroprotection by an angiotensin II blocker in an ex vivo retinal explant model.
White AJ; Heller JP; Leung J; Tassoni A; Martin KR
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1193-201. PubMed ID: 25628311
[TBL] [Abstract][Full Text] [Related]
2. A mouse retinal explant model for use in studying neuroprotection in glaucoma.
Pattamatta U; McPherson Z; White A
Exp Eye Res; 2016 Oct; 151():38-44. PubMed ID: 27450912
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of angiotensin II type 1 receptor (AT1-R) blocker via modulating AT1-R signaling and decreased extracellular glutamate levels.
Fujita T; Hirooka K; Nakamura T; Itano T; Nishiyama A; Nagai Y; Shiraga F
Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):4099-110. PubMed ID: 22661470
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of angiotensin II type 1 receptor blocker in a rat model of chronic glaucoma.
Yang H; Hirooka K; Fukuda K; Shiraga F
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5800-4. PubMed ID: 19608537
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers.
Sakuta T; Morita Y; Satoh M; Fox DA; Kashihara N
Arthritis Rheum; 2010 May; 62(5):1319-28. PubMed ID: 20213806
[TBL] [Abstract][Full Text] [Related]
7. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts.
Burger D; Montezano AC; Nishigaki N; He Y; Carter A; Touyz RM
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1898-907. PubMed ID: 21597004
[TBL] [Abstract][Full Text] [Related]
8. PPARgamma-activating angiotensin type-1 receptor blockers induce adiponectin.
Clasen R; Schupp M; Foryst-Ludwig A; Sprang C; Clemenz M; Krikov M; Thöne-Reineke C; Unger T; Kintscher U
Hypertension; 2005 Jul; 46(1):137-43. PubMed ID: 15939809
[TBL] [Abstract][Full Text] [Related]
9. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
[TBL] [Abstract][Full Text] [Related]
10. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance.
Shinozaki K; Ayajiki K; Nishio Y; Sugaya T; Kashiwagi A; Okamura T
Hypertension; 2004 Feb; 43(2):255-62. PubMed ID: 14698997
[TBL] [Abstract][Full Text] [Related]
11. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats.
Tamura T; Jamous MA; Kitazato KT; Yagi K; Tada Y; Uno M; Nagahiro S
J Hypertens; 2009 Jun; 27(6):1284-92. PubMed ID: 19307983
[TBL] [Abstract][Full Text] [Related]
12. NADPH oxidase-dependent formation of reactive oxygen species contributes to angiotensin II-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells.
Chang J; Jiang Z; Zhang H; Zhu H; Zhou SF; Yu X
Int J Mol Med; 2011 Sep; 28(3):405-12. PubMed ID: 21537828
[TBL] [Abstract][Full Text] [Related]
13. Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
Prasad T; Roksnoer LC; Zhu P; Verma A; Li Y; Batenburg WW; de Vries R; Danser AH; Li Q
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6722-6730. PubMed ID: 27951594
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species.
Lijnen P; Papparella I; Petrov V; Semplicini A; Fagard R
J Hypertens; 2006 Apr; 24(4):757-66. PubMed ID: 16531806
[TBL] [Abstract][Full Text] [Related]
15. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor type 1 blockers suppress the cell proliferation effects of angiotensin II in breast cancer cells by inhibiting AT1R signaling.
Du N; Feng J; Hu LJ; Sun X; Sun HB; Zhao Y; Yang YP; Ren H
Oncol Rep; 2012 Jun; 27(6):1893-903. PubMed ID: 22426690
[TBL] [Abstract][Full Text] [Related]
17. Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.
Matsui T; Yamagishi S; Takeuchi M; Ueda S; Fukami K; Okuda S
Pharmacol Res; 2010 Jan; 61(1):34-9. PubMed ID: 19635564
[TBL] [Abstract][Full Text] [Related]
18. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
19. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
[TBL] [Abstract][Full Text] [Related]
20. Improved gastric emptying in diabetic rats by irbesartan via decreased serum leptin and ameliorated gastric microcirculation.
He L; Sun Y; Zhu Y; Ren R; Zhang Y; Wang F
Genet Mol Res; 2014 Sep; 13(3):7163-72. PubMed ID: 25222222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]